SCHEMBL25892808

SCHEMBL25892808

Cc1nc(C(F)(F)F)ccc1SN1[C@@H]2CC[C@H]1CC(NC1CC3(COC3)C1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25892173 0.82 IRAK4 (0.34) —
SCHEMBL25316465 0.80 HSD11B1 (0.37) —
SCHEMBL25316461 0.80 HSD11B1 (0.37) —
SCHEMBL26029439 0.79 — —
SCHEMBL25892125 0.77 PTGS2 (0.37) —
SCHEMBL26026780 0.75 SCN9A (0.32) —
SCHEMBL27346544 0.73 GRIN2B (0.31) —
SCHEMBL30719523 0.72 TRPV4 (0.39) —
SCHEMBL25890475 0.72 HTR2A (0.33) —
SCHEMBL27346072 0.71 PTGS2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141323-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-07-27 — — WO disclosed
Send feedback